BioCentury
ARTICLE | Clinical News

AmpliPhi BioSciences, Celladon preclinical data

August 5, 2013 7:00 AM UTC

In rat models of PAH, Mydicar administered through a nebulizer-like inhalation device completely reversed the disease. Data were published in Circulation. A single intracoronary infusion of the recomb...